BURLINGTON, N.C., June 12, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”), has priced an offering of $570 million of senior secured notes due 2030 (the “Notes”), in connection with the previously announced spinoff of Fortrea into a … Read more
BURLINGTON, N.C., June 12, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”): The record date will be 5:00 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and … Read more
BURLINGTON, N.C., June 9, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”): The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and … Read more
BURLINGTON, N.C., June 8, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”), has launched an offering of senior secured notes due 2030 (the “Notes”), subject to market conditions and other customary factors, in connection with the previously announced … Read more
Liquid biopsy test for cancer patients enables oncologists to identify targeted therapies and improve care BURLINGTON, N.C., May 31, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for patients with advanced or metastatic solid tumors. The test … Read more